 high blood cholesterol level drugs Cost-effectiveness pharmacologic management cost-effectiveness analysis pharmacologic treatment high blood cholesterol levels Agents cholestyramine colestipol gemfibrozil lovastatin niacin probucol Pharmacologic effectiveness studies Cost estimates societal resource consumption Annual costs therapy niacin lovastatin mg/d Niacin efficient agent low-density lipoprotein cholesterol levels average cost years percent reduction low-density lipoprotein cholesterol level Lovastatin mg/d efficient percent reduction Cholestyramine efficient high-density lipoprotein cholesterol niacin efficient percent increase high-density lipoprotein cholesterol level gemfibrozil Analyses low-density lipoprotein cholesterol high-density lipoprotein cholesterol effects niacin lovastatin mg/d efficient cardiovascular risk